These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 36640323)
81. Crosstalk Between NDP52 and LUBAC in Innate Immune Responses, Cell Death, and Xenophagy. Miyashita H; Oikawa D; Terawaki S; Kabata D; Shintani A; Tokunaga F Front Immunol; 2021; 12():635475. PubMed ID: 33815386 [TBL] [Abstract][Full Text] [Related]
82. Shigella flexneri suppresses NF-κB activation by inhibiting linear ubiquitin chain ligation. de Jong MF; Liu Z; Chen D; Alto NM Nat Microbiol; 2016 May; 1(7):16084. PubMed ID: 27572974 [TBL] [Abstract][Full Text] [Related]
83. Human HOIP and LUBAC deficiency underlies autoinflammation, immunodeficiency, amylopectinosis, and lymphangiectasia. Boisson B; Laplantine E; Dobbs K; Cobat A; Tarantino N; Hazen M; Lidov HG; Hopkins G; Du L; Belkadi A; Chrabieh M; Itan Y; Picard C; Fournet JC; Eibel H; Tsitsikov E; Pai SY; Abel L; Al-Herz W; Casanova JL; Israel A; Notarangelo LD J Exp Med; 2015 Jun; 212(6):939-51. PubMed ID: 26008899 [TBL] [Abstract][Full Text] [Related]
84. Formation and removal of poly-ubiquitin chains in the regulation of tumor necrosis factor-induced gene activation and cell death. Kupka S; Reichert M; Draber P; Walczak H FEBS J; 2016 Jul; 283(14):2626-39. PubMed ID: 26749412 [TBL] [Abstract][Full Text] [Related]
85. SPATA2 and CYLD inhibit T cell infiltration into colorectal cancer Tan TG; Zybina Y; McKenna C; Olow A; Rukmini SJ; Wong MT; Sadekova S; Chackerian A; Bauché D Front Oncol; 2022; 12():1016307. PubMed ID: 36531014 [TBL] [Abstract][Full Text] [Related]
86. Linear ubiquitination in immune and neurodegenerative diseases, and beyond. Tokunaga F; Ikeda F Biochem Soc Trans; 2022 Apr; 50(2):799-811. PubMed ID: 35343567 [TBL] [Abstract][Full Text] [Related]
87. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal. Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631 [TBL] [Abstract][Full Text] [Related]
88. Molecular Determinants of Scaffold-induced Linear Ubiquitinylation of B Cell Lymphoma/Leukemia 10 (Bcl10) during T Cell Receptor and Oncogenic Caspase Recruitment Domain-containing Protein 11 (CARD11) Signaling. Yang YK; Yang C; Chan W; Wang Z; Deibel KE; Pomerantz JL J Biol Chem; 2016 Dec; 291(50):25921-25936. PubMed ID: 27777308 [TBL] [Abstract][Full Text] [Related]
89. The antiviral action of the RIG-I induced pathway of apoptosis (RIPA) is enhanced by its ability to degrade Otulin, which deubiquitinates IRF3. Raja R; Sen GC Cell Death Differ; 2022 Mar; 29(3):504-513. PubMed ID: 34545182 [TBL] [Abstract][Full Text] [Related]
90. The Met1-linked ubiquitin machinery in inflammation and infection. Fiil BK; Gyrd-Hansen M Cell Death Differ; 2021 Feb; 28(2):557-569. PubMed ID: 33473179 [TBL] [Abstract][Full Text] [Related]
91. The Meschede J; Šadić M; Furthmann N; Miedema T; Sehr DA; Müller-Rischart AK; Bader V; Berlemann LA; Pilsl A; Schlierf A; Barkovits K; Kachholz B; Rittinger K; Ikeda F; Marcus K; Schaefer L; Tatzelt J; Winklhofer KF Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019898 [TBL] [Abstract][Full Text] [Related]
92. A20 inhibits LUBAC-mediated NF-κB activation by binding linear polyubiquitin chains via its zinc finger 7. Verhelst K; Carpentier I; Kreike M; Meloni L; Verstrepen L; Kensche T; Dikic I; Beyaert R EMBO J; 2012 Oct; 31(19):3845-55. PubMed ID: 23032186 [TBL] [Abstract][Full Text] [Related]
93. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling. Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971 [TBL] [Abstract][Full Text] [Related]
95. Crucial Role of Linear Ubiquitin Chain Assembly Complex-Mediated Inhibition of Programmed Cell Death in TLR4-Mediated B Cell Responses and B1b Cell Development. Sasaki Y; Iwai K J Immunol; 2018 May; 200(10):3438-3449. PubMed ID: 29654209 [TBL] [Abstract][Full Text] [Related]
97. Structural basis for the simultaneous recognition of NEMO and acceptor ubiquitin by the HOIP NZF1 domain. Rahighi S; Iyer M; Oveisi H; Nasser S; Duong V Sci Rep; 2022 Jul; 12(1):12241. PubMed ID: 35851409 [TBL] [Abstract][Full Text] [Related]
98. The linear ubiquitin assembly complex (LUBAC) is essential for NLRP3 inflammasome activation. Rodgers MA; Bowman JW; Fujita H; Orazio N; Shi M; Liang Q; Amatya R; Kelly TJ; Iwai K; Ting J; Jung JU J Exp Med; 2014 Jun; 211(7):1333-47. PubMed ID: 24958845 [TBL] [Abstract][Full Text] [Related]
99. Genetic deletion and pharmacologic inhibition of E3 ubiquitin ligase HOIP impairs the propagation of myeloid leukemia. Jimbo K; Hattori A; Koide S; Ito T; Sasaki K; Iwai K; Nannya Y; Iwama A; Tojo A; Konuma T Leukemia; 2023 Jan; 37(1):122-133. PubMed ID: 36352193 [TBL] [Abstract][Full Text] [Related]
100. LUBAC and NF-κB trigger a nuclear response from mitochondria. Chen J; Simmen T EMBO J; 2022 Dec; 41(24):e112920. PubMed ID: 36398765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]